糖尿病药物可以降低阿尔茨海默氏病的风险,但JAMA神经学研究表明,还需要开展更多的研究。 Diabetes medications may reduce Alzheimer's risk, but more research is needed, JAMA Neurology studies suggest.

包括Ozempic在内的糖尿病药物可能会降低阿尔茨海默氏病和其他痴呆症的风险,根据JAMA神经学的研究。 Diabetes drugs, including Ozempic, may lower the risk of Alzheimer's disease and other dementias, according to studies in JAMA Neurology. 美国的一项研究发现,与老药相比,GLP-1RAs和SGLT2is分别与33%和43%的痴呆病风险有关。 A US study found that GLP-1RAs and SGLT2is were associated with 33% and 43% lower risks of dementia, respectively, compared to older drugs. 调查结果虽然很有希望,但基于短期的后续行动,需要开展更多的研究来确认这种关系。 While promising, the findings are based on short follow-ups, and more research is needed to confirm the relationship.